Het rapport
Geverifieerd nieuws over financiering, hoofdkantoren en leiderschap van 's werelds meest innovatieve bedrijven
14 rapporten en meer
ProtaGene Appoints Matthias Bucerius Chief Executive Officer
ProtaGene appointed former Merck KGaA CDMO senior vice president Matthias Bucerius as CEO, effective immediately, to work with its Presidents on timelines, data quality, and analytical science.
NeoGenomics Names Warren Stone Chief Executive Officer
NeoGenomics named President and COO Warren Stone CEO effective January 4, 2027, with Tony Zook becoming Executive Chair and the company emphasizing strategic continuity.
Remepy Raises $36M Series A to Advance Hybrid Drug Pipeline
Remepy raised a $36 million Series A led by O.G. Venture Partners and M Ventures to expand its Hybrid Drug pipeline and fund Phase III development of Hybridopa for Parkinson’s disease.
Infinimmune Raises $75M Series A for Human-Derived Antibody Drugs
Infinimmune raised a $75 million Series A co-led by Regeneron Ventures and Playground Global to advance human-derived antibody programs in atopic dermatitis and inflammatory disease.
Tessera Therapeutics Appoints Joseph Romanelli President and Chief Executive Officer
Tessera Therapeutics appointed Joseph Romanelli, most recently a Merck executive, as President and CEO, succeeding Michael Severino, as the company shifts from platform innovation toward a broad portfolio of Gene Writing medicines.
Merck Raises $180B in Public
Merck, a Pharmaceutical company based in 126 E Lincoln Avenue, Rahway, NJ 07065, has raised $180B in Public at a $190B valuation led by Public.
Merck raises $180B Public at $190B valuation
Merck raises $180B in Public at $190B valuation. Pharmaceutical company...
Merck & Co Raises $280B in Public
Merck & Co, a Pharmaceuticals company based in 126 East Lincoln Avenue, Rahway, NJ 07065, has raised $280B in Public at a $300B valuation led by Public.
Merck & Co raises $280B Public at $300B valuation
Merck & Co raises $280B in Public at $300B valuation. Pharmaceutical company...
Tonen van 9 rapporten • Pagina 1 • Categorie: all
Loop voor op de markt
Ontvang wekelijkse inzichten in uw inbox. Geen spam, alleen intelligentie.